People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lodo Therapeutics Corp | — | Biotechnology | Series B | $19.9M | $788.5M | 2015 |
David Johnston Pompliano at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Johnston Pompliano on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Asish Xavier | 1 | 18 |
| Steve Gillis | 1 | 13 |
| Thong Le | 1 | 12 |
| Joel Johnston Marcus | 1 | 5 |
| M. Johnston Erwin | 1 | 5 |
| Barbara Johnston Dalton | 1 | 3 |
| James Johnston Sullivan | 1 | 3 |
| David Johnston Schubert | 1 | 3 |
| Lindsay Johnston Rayle | 1 | 3 |
| David Johnston McElligott | 1 | 2 |
| Misti Johnston Ushio | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.